US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

96.94

+0.26000.27%

Post-market: 96.940.00000.00%19:30 EDT

Volume:9K

Turnover:882.27K

Market Cap:399.39M

PE:54.06

High:96.95

Open:96.84

Low:96.67

Close:96.68

52wk High:98.82

52wk Low:67.69

Shares:4.12M

Float Shares:4.12M

Volume Ratio:0.47

T/O Rate:0.22%

Dividend:1.55

Dividend Rate:1.60%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.61

PE(LYR):5.20

Loading ...

Overview Company News Filings

Alnylam to present new clinical data on ATTR, hypertension at ESC Congress

Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.

Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease

THOMSON REUTERS

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.

Funds: What a Top Biotech Fund is Buying Now

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-08-21

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial

Biogen Inc. Stock Underperforms Thursday When Compared to Competitors

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-20

Wall Street Analysts Are Bullish on Top Healthcare Picks

Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 11 of 19 Names at New Peaks

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PBE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":96.94,"timestamp":1788292800000,"preClose":96.68,"halted":0,"volume":9114,"hourTrading":{"tag":"盘后","latestPrice":96.94,"preClose":96.94,"latestTime":"19:30 EDT","volume":13,"amount":1259.92,"timestamp":1788305405313,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0026892842366569186,"floatShares":4120000,"shares":4120000,"eps":1.793292,"marketStatus":"Closed","change":0.26,"latestTime":"09-01 16:00:00 EDT","open":96.84,"high":96.95,"low":96.665,"amount":882271.8018240001,"amplitude":0.002948,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":96.68,"sharesOutstanding":3180000,"nav":96.62604,"aum":475400116.8,"dividendRate":0.015957,"bidAskSpread":0.001816,"preHourTrading":{"tag":"盘前","latestPrice":97.83,"preClose":96.68,"latestTime":"05:50 EDT","volume":5,"amount":486.63,"timestamp":1788256220934,"change":1.15,"changeRate":0.011895,"amplitude":0.026065},"postHourTrading":{"tag":"盘后","latestPrice":96.94,"preClose":96.94,"latestTime":"19:30 EDT","volume":13,"amount":1259.92,"timestamp":1788305405313,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.470517,"impliedVol":0.1136,"impliedVolPercentile":0.0159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4120000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.470517,"shares":4120000,"dividePrice":1.5469,"high":96.95,"amplitude":0.002948,"preClose":96.68,"low":96.665,"week52Low":67.69,"pbRate":"1.61","psRate":"232.66","week52High":98.82,"institutionHeld":0.2552,"latestPrice":96.94,"eps":1.793292,"divideRate":0.015957,"volume":9114,"delay":0,"ttmEps":1.793292,"open":96.84,"prevYearClose":82.15,"prevWeekClose":96.32,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":98.7315,"twentyDayClose":91.53,"sixtyDayClose":83.4781},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661279552","title":"Alnylam to present new clinical data on ATTR, hypertension at ESC Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279552","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279552?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575225,"startTime":"0","endTime":"0","summary":"Alnylam (ALNY) Pharmaceuticals announced that it will present new clinical and real-world data across its transthyretin-mediated amyloidosis, ATTR,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU0882574055.USD","LU0114720955.EUR","BK4588","LU0109394709.USD","BK4139","BK4585","GNMX","ATTR","ALNY","LU0889565916.HKD","BK4548","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279670","title":"Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279670","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279670?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575209,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that once weekly lecanemab-irmb subcutaneous injection is now available in the U.S. for initiation therap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-once-weekly-lecanemab-irmb-availability-in-the-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-once-weekly-lecanemab-irmb-availability-in-the-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIIB","IE00B894F039.SGD","IE00B19Z9Z06.USD","BK4139","BK4585","BMED","BK4007","LU0320765992.SGD","LU0234570918.USD","IE00B19Z9P08.USD","LU0109394709.USD","BK4588","LU0889565916.HKD","BK4532","PBE","ESAIY","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661313276","title":"Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661313276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661313276?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:02","pubTimestamp":1787572944,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B894F039.SGD","BK4588","LU0109394709.USD","IE00B19Z9Z06.USD","LU0234570918.USD","PBE","BK4532","BMED","LU0889565916.HKD","IE00B19Z9P08.USD","BK4139","BK4585","LU0320765992.SGD","BIIB","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222504","title":"Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222504","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554851,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo names Ken Keller chief commercialization officer, effective April 2027Daiichi Sankyo named Ken Keller chief commercialization officer, effective April 1, 2027, to run a new globally int","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLbyMxfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4566","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4533","LU2089984988.USD","AMGN","IE00BJJMRZ35.SGD","LU2242646821.SGD","LU1983299246.USD","LU2468319806.SGD","SG9999001440.SGD","LU2112291526.USD","LU0320765992.SGD","LU1571399168.USD","IBBQ","LU0289739699.SGD","LU1057294990.SGD","IE00B2B36J28.USD","TBXU","BK4534","PBE","IE00BJT1NW94.SGD","LU2242652126.USD","LU0868494617.USD","BK4585","IBB","LU0889565916.HKD","BK4599","LU0058720904.USD","BK4581","PJP","LU0122379950.USD","BBH","IE0009355771.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","BIB","LU0109394709.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228075","title":"Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228075","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228075?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:29","pubTimestamp":1787542174,"startTime":"0","endTime":"0","summary":"Earlier in August 2026, VIAVI Solutions launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and support for carrier frequencies up to 23.6 GHz, targeting next-generation 6G and Wi‑Fi 7/8 testing and integrating real-world RF propagation into lab environments.\nThis upgrade, the first since acquiring Spirent’s high-speed Ethernet, network security and channel emulation testing business, positions Vertex 6.0 as a modular RF digital twin platform...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IBBQ","IE0002141913.USD","LU2236285917.USD","SG9999013999.USD","LU0240877869.USD","LU2065171311.SGD","AGIX","LU0432979614.USD","IE00B19Z9Z06.USD","LU2065170008.USD","LU1585245621.USD","BK4532","AIPO","IDNA","SG9999001176.SGD","LU2065171402.SGD","BK4588","LU1069344957.HKD","QTOC","LU2089984988.USD","LU1559883803.SGD","PBE","VERX","BBH","LU0109394709.USD","VTHR","VIAG","LU1093756325.SGD","LU2417539215.USD","LU2462157665.USD","LU0889565916.HKD","VIAV","VRTX","BK4567","CHAT","GNMX","IE00B4R5TH58.HKD","BK4023","LU1674673428.USD","BIB","TBXU","LU0061475181.USD","ARTY","LU0234570918.USD","IBB","BK4585","LU2362540622.SGD","LU0205194284.USD","LU0417517546.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","LU0417517546.SGD","LU0053666078.USD","LU0882574055.USD","LU1778281490.HKD","IE0002270589.USD","BIB","LU1934455194.USD","GNMX","LU0256863811.USD","BK4532","LU0122379950.USD","LU2362540622.SGD","LU2462157665.USD","LU0823434583.USD","LU1430594728.SGD","SG9999001440.SGD","IE00B19Z9P08.USD","TMED","LU2242646821.SGD","LU0965508806.USD","LU1571399168.USD","IE00BZ9MQY76.HKD","LU2106854487.HKD","SG9999015978.USD","LU1839511570.USD","LU1023059063.AUD","BK4599","IE00BN0W2T93.GBP","LU0234570918.USD","LU0154245673.USD","LU2236285917.USD","BK4566","LU1037948897.HKD","LU0965509283.SGD","LU1974910355.USD","AMGN","LU0859254822.USD","LU1069344957.HKD","LU2324357040.USD","LU0109394709.USD","IE00B2B36J28.USD","LU0823434740.USD","IE00B3T34201.USD","LU1057294990.SGD","LU1934455277.USD","LU0079474960.USD","LU0861579265.USD","SG9999001176.USD","LU0965509010.AUD","LU2468319806.SGD","LU2362541513.USD","REGN","BBH","IE00BN0W2W23.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0114720955.EUR","LU0061475181.USD","LU1037948541.HKD","LU0320765992.SGD","MEDI","SG9999015986.USD","LU1066051498.USD","LU2023250504.SGD","IE00B19Z9Z06.USD","LU0058720904.USD","LU2417539215.USD","IBB","IE00B894F039.SGD","LU2087621335.USD","JAZZ","IE00B19Z3B42.SGD","LU1066053197.SGD","IE00BSNM7G36.USD","LU1035775433.USD","LU0868494617.USD","SG9999013999.USD","SG9999001176.SGD","IE0002141913.USD","IE0009355771.USD","LU1093756168.USD","VRTX","LU2362541273.HKD","IE00BJJMRZ35.SGD","LU1674673691.USD","LU1585245621.USD","SG9999015952.SGD","BMED","BK4583","IE00B7SZLL34.SGD","LU0432979614.USD","LU1061106388.HKD","BK4585","LU1674673428.USD","IE00B4R5TH58.HKD","BK4578","LU2357627491.SGD","TBXU","LU0889565916.HKD","BK4007","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","BK4139","BK4568","LU2237438978.USD","IBBQ","PBE","IE00BN0W2V16.EUR","BK4581","BK4534","IDNA","LU0154245756.USD","PJP","XBI","SGXZ57979304.SGD","BK4588","SG9999015945.SGD","BK4533","LU2089984988.USD","LU0965509101.SGD","IE00BKVL7J92.USD","LU0823416689.USD","LU1934455863.HKD","04332","BK4550","BK4567","LU1983299246.USD","LU1917777945.USD","LU2456880835.USD","GILD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661375290","title":"Biogen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2661375290","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661375290?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:57","pubTimestamp":1787345820,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  advanced 1.13% to $216.78 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.43% to 7,674.37 and the Dow Jones Industrial Average  rising 0.98% to 53,277.01.Biogen Inc. closed 2.42% below its 52-week high of $222.15, which the company achieved on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 1.07% to $270.24, Pfizer Inc.  rose 1.01% to $28.07, and AbbVie Inc.  rose 1.20% to $264.96.Trading volume  remained 497,941 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4585","LU0320765992.SGD","PBE","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","LU0889565916.HKD","BK4139","BK4532","BMED","IE00B894F039.SGD","LU0234570918.USD","BIIB","BK4533","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661292659","title":"NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-08-21","url":"https://stock-news.laohu8.com/highlight/detail?id=2661292659","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661292659?lang=en_us&edition=fundamental","pubTime":"2026-08-22 02:45","pubTimestamp":1787337906,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-08-21Nasdaq 100.NDXTop PerformersPercent ChangeTesla IncTSLA.OQ+5.5%Strategy IncMSTR.OQ+5.4%Ross Stores IncROST.OQ+5.0%Alnylam Pharmaceuticals, Inc.ALNY.OQ+3.3%Palantir Technologies Inc.PLTR.OQ+3.0%Bottom PerformersPercent ChangeMarvell Technology, Inc.MRVL.OQ-5.5%American Electric Power Company IncAEP.OQ-3.2%ARM Holdings PLCARM.OQ-2.9%Xcel Energy IncXEL.OQ-2.4%Exelon CorpEXC.OQ-2.2%The Nasdaq 100.NDXgained 73.82 points, or 0.25%, to 29,286.98 and recorded 2 new highs and one new low. 65 stocks rose and 37 fell as advancing issues outnumbered decliners by a about a 1.8-to-1 ratio.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I146:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDRV","LU2360107168.USD","LU2213496289.HKD","ARMW","LU1992135399.USD","UPW","LU2346227817.USD","LU1232071149.USD","LU0708995401.HKD","IE00BK4W5M84.HKD","BK4574","LU1435385759.SGD","LU2506951958.HKD","PLOO","LU0823417737.USD","IE00BBT3K403.USD","XNTK","LU0882574055.USD","MSTY","PLTI","FXL","LU0466842654.USD","LU0689472784.USD","PBE","MSTK","BK4596","BK4551","IE00B19Z8W00.USD","SG9999015986.USD","LU2272731782.SGD","LU2244417387.USD","IE00B19Z9Z06.USD","LU0820561818.USD","LU0823434583.USD","TSLS","BK4606","LU0053666078.USD","TSDD","LU2362541273.HKD","WATS","ARTY","LU2462157665.USD","MSII","TSLG","XEL","MSTX","SG9999015978.USD","07766","LU0345769631.USD","ARMG","MSST","LU0077335932.USD","IE00B29SXK94.USD","LU1303367103.USD","LU2506952170.USD","PLTZ","LU0823417653.USD","LU1066051225.USD","IE00B19Z3B42.SGD","LU1894683264.USD","PLTL","MSTW","IE00BMQBXF63.USD","TSII","MRVU","LU1778281490.HKD","LU1066051498.USD","SG9999015945.SGD","LU0444973449.USD","TSLA","MSTU","LU0081259029.USD","3SMI.UK","LU2417539215.USD","LU1551013342.USD","LU2750360997.AUD","BK4612","LU1066051811.HKD","07799","LMI3.UK","LU2456880835.USD","LU0719512351.SGD","LU2108987350.USD","FXU","LU0823421416.USD","MVLL","PLTG","LU2506951875.HKD","MST","LU0187121727.USD","IE00BZ9MQY76.HKD","ELOL","LU0889565916.HKD","IE0034235303.USD","LU1366192091.USD","GNMX","LU2403377893.USD","BK4595","LU2473716301.USD","OWNB","TSLI","LU0082616367.USD","MSTC","CRSH","LU0820561909.HKD","LU0274383776.USD","LU1894683348.USD","LU2168564222.USD","TSLP","BK4600","IE00B29SXL02.USD","LU0957808578.USD","LU1914381329.SGD","BK4585","URAN","XLU","TSLW","IE0002270589.USD","BK4555","LU0323591593.USD","07399","IE00BSNM7G36.USD","LU2023250330.USD","BK4581","LU0314106906.USD","LU1267930730.SGD","BK4598","MSTZ","MSTY.UK","IMST","LU0056508442.USD","09399","BK4543","IE00BMPRXN33.USD","TRFK","LU2506952097.USD","BK4023","LU0345769128.USD","LU0127658192.USD","BILT","LU2471134796.USD","PLTY","ALNY","ARMA","LU0823434740.USD","LU1861220033.SGD","IE00BMPRXQ63.HKD","AIS","MRVL","IE00BN8TJ469.HKD","BK4547","LU1261432733.SGD","BK4534","IGV","LU2931357623.SGD","FDTX","LU0345770308.USD","IE00BMPRXR70.SGD","LU2357305700.SGD","IE00B19Z9505.USD","HK0000914660.USD","BK4592","EYES","TSLL","TSL","LU2471134879.HKD","IE0004091025.USD","TESC","BK4516","ZAP","IE00B19Z8X17.USD","LU2063271972.USD","FTXL","LU2896262040.SGD","LU0198837287.USD","BK4613","IE00BLSP4239.USD","LU0266013472.USD","BK4533","LU0786609619.USD","FAI","LU1316542783.SGD","CRPT","LU2326559502.SGD","TSLZ","LU2471134952.CNY","LU1839511570.USD","LU1674673428.USD","IE0004086264.USD","LU0345770993.USD","BK4604","PLT","LU1169590202.USD","LU0048573561.USD","LU1989764748.USD","LU1235294995.USD","LU1093756325.SGD","LU2500361329.USD","IDRV","LU0823411888.USD","LU0348723411.USD","LU0672654240.SGD","LU1823568750.SGD","MSOO","LU2168564065.EUR","LU1989764664.SGD","IE00B1XK9C88.USD","QQQA","LU2360106780.USD","LU1861215975.USD","09366","TESL","09799","IE00BWXC8680.SGD","IE00BK4W5L77.USD","ARM","LU1674673691.USD","LU0320765059.SGD","LU0061475181.USD","LU2637428348.USD","BK4588","LU2250418816.HKD","LU0985320562.USD","MRVX","BK4605","TSLQ","BK4141","IE00B19Z9P08.USD","TSYY","LU2168564149.EUR","LU2750360641.GBP","3LMI.UK","LU0109391861.USD","BK4550","AEP","ROST","LU1551013425.SGD","LU0444971666.USD","SMHX","LU2272731865.HKD","LU1506573853.SGD","LU1861558580.USD","LU0964807845.USD","BK4527","LU2362541513.USD","LU2290526834.HKD","MTYY","LU1046421795.USD","LU2756315318.SGD","IE00B1BXHZ80.USD","LU1629891620.HKD","BK4094","GUNZ","LU0114720955.EUR","LU2463526074.USD","LU0109394709.USD","LU1718418525.SGD","09766","DTCR","BK4548","EXC","LU2236285917.USD","IE00BJLML261.HKD","SG9999000418.SGD","TRUU","LU1852331112.SGD","WNTR","LU1720051108.HKD","MSDD","LU2420271590.USD","SPLTRmain","LU0210536198.USD","LU0316494557.USD","LU0950375773.USD","LU2458330169.SGD","HK0000914686.HKD","GTEK","IE00B894F039.SGD","LU2602419157.SGD","LU2471134523.USD","IE00BLSP4452.SGD","LU0154236417.USD","ARMU","SG9999015952.SGD","WUGI","LU2322448791.USD","BK4139","WANT","SPRX","LU2322448957.HKD","MSTR","LU0133085943.USD","PLTW","LU2087621335.USD","BK4609","IE00BZ18W456.USD","LU2272731600.USD","LU1642822529.SGD","TSLT","LU2168563687.JPY","LU2449327464.USD","LU0251142724.SGD","SMOG","LU2362540622.SGD","LU0742534661.SGD","LU2098885051.SGD","TEST","LU0642271901.SGD","AIFD","PLTA","SOXY","LU0820562030.AUD","MSTP","TSLO","BK4081","LU1992135472.HKD","LU2168564495.EUR","LU2458330243.SGD","LU1815336760.USD","LU0943347566.SGD","RSPU","07366","LU0476273544.USD","FUTY","LU0251131958.USD","AIPI","VPU","BK4511","LU1066053197.SGD","LU1145028129.USD","TLA","PLTD","LU1548497426.USD","BK4515","UTES","LU1119994496.HKD","LU0823414478.USD","LU1169589451.USD","TSLY","IE00B19Z3581.USD","SHLD","LU1084165304.USD","TSLR","IE00B7SZLL34.SGD","PLYY","IE00B3T34201.USD","LIT","LU1861559042.SGD","LU1429558221.USD","BITQ","SMST","LU0097036916.USD","LU1093756168.USD","BK4099","PLTU","LU2089985449.USD","LU1720051017.SGD","PLTR","JXI","LU2543165471.USD","LU0823421333.USD","IE00BZ18W340.USD","LU0234572021.USD","SMI3.UK","RNWZ","LU2249611893.SGD","PTIR","APED","LU2756315664.SGD","LU0170899867.USD","LU0234570918.USD","LU0320765992.SGD","STSLAmain"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2661887294","title":"Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661887294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661887294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:34","pubTimestamp":1787330049,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 DeLLphi-315 study tests its cancer drug tarlatamab in pe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE0002141913.USD","LU1023059063.AUD","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","LU2242652126.USD","BK4585","BK4581","PJP","IBB","LU2242646821.SGD","BK4534","BIB","LU2089984988.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","BK4599","LU1983299246.USD","LU0122379950.USD","BBH","IE00BJT1NW94.SGD","IBBQ","BK4566","LU0289739699.SGD","LU1061106388.HKD","TBXU","LU0868494617.USD","LU0320765992.SGD","LU2468319806.SGD","IE0009355771.USD","LU1057294990.SGD","AMGN","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139","LU2112291526.USD","BK4533","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294871","title":"Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294871","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661294871?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:33","pubTimestamp":1787330033,"startTime":"0","endTime":"0","summary":"Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Biogen Inc. has launched a Phase 2 trial testing felzartamab in adults wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biogen-expands-autoimmune-pipeline-with-new-graves-disease-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biogen-expands-autoimmune-pipeline-with-new-graves-disease-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIIB","LU0109394709.USD","BK4588","LU0889565916.HKD","IE00B19Z9Z06.USD","BMED","IE00B894F039.SGD","BK4533","BBC","BK4139","IE00B19Z9P08.USD","LU0320765992.SGD","PSIL","BK4585","BK4532","PBE","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661523754","title":"Biogen Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661523754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661523754?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:56","pubTimestamp":1787259360,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slid 3.25% to $214.35 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a two-day winning streak.Biogen Inc. closed 3.51% short of its 52-week high of $222.15, which the company achieved on August 19th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and AbbVie Inc.  fell 1.56% to $261.83.Trading volume  remained 414,428 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","BIIB","PBE","BK4533","LU0889565916.HKD","BK4532","BK4585","BMED","IE00B19Z9Z06.USD","BK4588","LU0234570918.USD","IE00B894F039.SGD","LU0109394709.USD","LU0320765992.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323699","title":"Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323699","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323699?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243431,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 2b study A Phase 2b, Open-label Study to Evaluat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","LU2362541513.USD","LU1674673428.USD","LU2362540622.SGD","BK4567","IBBQ","BK4588","IE00B19Z9P08.USD","SG9999001176.USD","LU0757428866.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU0889565916.HKD","IE00B2B36J28.USD","IDNA","IE00B19Z3581.USD","LU2324357040.USD","SG9999013999.USD","LU0566484027.USD","TBXU","VRTX","BK4139","LU2362541273.HKD","PBE","LU1093756325.SGD","LU1815336091.USD","LU0234570918.USD","LU2417539215.USD","LU1093756168.USD","IE0002141913.USD","LU2468319806.SGD","BK4585","LU1069344957.HKD","LU2456880835.USD","LU1674673691.USD","LU0289739699.SGD","LU0256863811.USD","LU0079474960.USD","BIB","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2237438978.USD","IE00B894F039.SGD","SG9999001176.SGD","BBH","LU2089984988.USD","LU0432979614.USD","IBB","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660336672","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-20","url":"https://stock-news.laohu8.com/highlight/detail?id=2660336672","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660336672?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:01","pubTimestamp":1787238067,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-08-20Nasdaq 100.NDXTop PerformersPercent ChangeStrategy IncMSTR.OQ+5.4%Lumentum Holdings Inc.LITE.OQ+4.4%Seagate Technology Holdings PLCSTX.OQ+3.8%Marvell Technology, Inc.MRVL.OQ+3.3%Diamondback Energy, Inc.FANG.OQ+2.9%Bottom PerformersPercent ChangeWalmart IncWMT.OQ-9.6%Space Exploration Technologies CorpSPCX.OQ-4.8%Alnylam Pharmaceuticals, Inc.ALNY.OQ-3.6%CrowdStrike Holdings, Inc.CRWD.OQ-3.2%Tesla IncTSLA.OQ-3.0%The Nasdaq 100.NDXlost 109.43 points, or 0.37%, to 29,316.59 and recorded one new high and no new lows. 51 stocks rose and 50 fell as advancing issues outnumbered decliners by a about a 1-to-1 ratio.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL8N44H186:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823421416.USD","LU0053666078.USD","WMT","09086","09399","LU0689472784.USD","LU0553294199.USD","MSDD","LU0056508442.USD","LU2290526834.HKD","TSII","LU0323591593.USD","TSLL","TSLS","LU2471134879.HKD","LU1720051108.HKD","LU2543165471.USD","07266","SG9999015978.USD","DISK","LU1823568750.SGD","LU0266013472.USD","TSLG","HK0000914660.USD","LU0823414478.USD","LU0061475181.USD","LU0466842654.USD","LU0133085943.USD","LU1084165304.USD","LU2087625088.SGD","LU1988902786.USD","MRVU","MSTU","IE00B19Z9Z06.USD","LU1003077747.HKD","SG9999015952.SGD","LU2286300806.USD","LU0820562030.AUD","LU1064131342.USD","LU1066051498.USD","BK4595","FDTX","LU0957791311.USD","LU2265009873.SGD","GTEK","LU0289739343.SGD","TSLP","LU0175139822.USD","IE00BMPRXR70.SGD","PBE","07522","LU2125909593.SGD","LUMA","HK0000914686.HKD","LU1267930730.SGD","LU0012050646.USD","LU2213496289.HKD","LU0205193047.USD","LU1951198990.SGD","LU2750360641.GBP","LU0345769631.USD","LU1674673428.USD","LU1814569148.SGD","LU0251131958.USD","LU1670628061.USD","TSDD","MSTR","LU0889565916.HKD","LU2458330243.SGD","09799","LIT","STX","BK4532","SG9999015986.USD","3SMI.UK","IE00B1XK9C88.USD","LU2106854487.HKD","LU0545039389.USD","LU0345770993.USD","BK4596","LU2430703251.USD","LU1035773651.USD","BK4588","LU0081259029.USD","LU2461242641.AUD","LU0203347892.USD","CLOD","TRUO","NOCT","LU2272731782.SGD","LU0240878834.USD","APED","07261","FOTO","LU0061474960.USD","IE00B894F039.SGD","LU1145028129.USD","BK4548","CRSH","LU0444973449.USD","TSLA","WMTI","HK0000819398.USD","03455","IE00BK4W5M84.HKD","LU1983260115.SGD","QQQA","CRPT","LU1815333072.USD","BK4600",".HXC","BK4512","LU2473716301.USD","BK4604","LU0345769128.USD","LU2456880835.USD","LU0256863811.USD","LU0642271901.SGD","IGV","LU0097036916.USD","MTYY","LU0109394709.USD","LU0661504455.SGD","LU2756315664.SGD","02834","MSTP","LU0708995401.HKD","XLP","LU2168563687.JPY","LU2505996509.AUD","LU2506951792.HKD","03086","LU2322448957.HKD","TLA","LITG","BK4516","LU0106261612.USD","LMI3.UK","LU0077335932.USD","NJUL","CIBR","BK4534","LU1951200564.SGD","LU2249611893.SGD","BK4555","IE00B2Q91V27.USD","WCBR","LITX","LU0964807845.USD","LU0048573561.USD","LU0289960550.SGD","LU1169590202.USD","LU2357125470.USD","IE0001KFT4U8.USD","LU1923623000.USD","LU1435385759.SGD","LU0234572021.USD","IE00BGHQF524.EUR","LU1261432733.SGD","BK4139","LU0640476718.USD","LU2089985449.USD","LU2125909916.SGD","DTCR","LU0719512351.SGD","LU1861559042.SGD","LU0096362180.USD","IE00B19Z9P08.USD","MVLL","LU2471134523.USD","LU2063271972.USD","LU0210536198.USD","LU2294711713.HKD","PSQ","TSLZ","BK4504","LU2896262040.SGD","LU1861220033.SGD","BK4550","LU2168564495.EUR","LU1303367103.USD","LU2168564222.USD","LU2264538146.SGD","LITE","LU1815336760.USD","AIS","SQQQ","LU0310799852.SGD","LU1548497426.USD","LU2458330169.SGD","LU1116320737.USD","FCUS","MSII","MSTZ","TQQY","LU0265550359.USD","PSWD","TESL","LU1923622614.USD","QLD","FSTA","LU1914381329.SGD","SMHX","LU2471134796.USD","LU0511384066.AUD","TSLW","LU1429558221.USD","QDEC","QQQM","LU0109391861.USD","MSTW","LU1839511570.USD","IE0004086264.USD","IE00BLSP4239.USD","07399","CRWD","SMST","TSLQ","LU1430594728.SGD","TQQQ","LU2746668461.USD","XNTK","IE00BSNM7G36.USD","LU1923622291.USD","ELOL","BK4585","LU0957808578.USD","LU0154236417.USD","LU2417539215.USD","LU0265550946.USD","BK4592","QID","LU2108987350.USD","IE000M9KFDE8.USD","LU2592432038.USD","TSL","NDX","LU1551013342.USD","LU2023250504.SGD","LU2125909759.SGD",".IXIC","AIPI","BK4511","MSTY","IE0034235303.USD","FAI","LU1778281490.HKD","GNMX","LU1585245621.USD","LU0240877869.USD","MRVL","OWNB","LU0149725797.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU0320765059.SGD","LU1974910355.USD","LU0114720955.EUR","QMAR","LU0882574055.USD","LU1674673691.USD","LU2272731600.USD","DRMY","UGE","BK4605","TEST","BK4543","LU1046421795.USD","LU0198837287.USD","LU0211328371.USD","IE00BK4W5L77.USD","LU0256863902.USD","LU1366192091.USD","LU2430703178.SGD","LU2381873111.SGD","LU0274383776.USD","IDRV","LU1642822529.SGD","LU2272731865.HKD","LU2360106780.USD","LU2211815571.USD","MSTK","SMOG","SPAM","BK4097","LU0823434583.USD","LU2361044949.HKD","STSLAmain","LU0823414551.USD","03034","LU0289961442.SGD","LU0444971666.USD","TSLO","LU2361045086.USD","WANT","LU2357305700.SGD","IE00B19Z8W00.USD","LU2125154935.USD","BK4597","LU0820561818.USD","IE00BZ9MQY76.HKD","BK4551","LU0238689110.USD","BK4560","LU2505996681.GBP","3LMI.UK","LU0211327993.USD","LU0943347566.SGD","LU2433249047.HKD","BK4612","IE00B3CCJ963.GBP","LU0823434740.USD","FDRV","NAPR","LU0353189680.USD","ALNY","BK4528","LU2125154778.USD","BUG","IE00BWXC8680.SGD","LU2125909247.SGD","BK4527","LU0823421333.USD","LU0320765992.SGD","LU0820561909.HKD","BK4155","LU2250418816.HKD","LU0314104364.USD","LU1316542783.SGD","IE00BMPRXQ63.HKD","LU0251142724.SGD","IE00BN8TJ469.HKD","WLDR","LU2360032135.SGD","SG9999000418.SGD","LU1804176565.USD","LU0417517546.SGD","LU0082616367.USD","LU0348723411.USD","LU2471134952.CNY","IE00BLSP4452.SGD","LU0823411888.USD","TSLT","QQQ","LU2236285917.USD","LU2361044865.SGD","FXL","LU0742534661.SGD","LU1169589451.USD","LU2098885051.SGD","IE00BBT3K403.USD","BK4170","LU2430703095.HKD","QQQG","LU1280957306.USD","LU1992135472.HKD","FTXL","RTH","IE0034235188.USD","TSYY","BK4141","LU0234570918.USD","HXC","LU2087621335.USD","OILT","07766","BK4099","AIFD","IE00BMPRXN33.USD","LU0187121727.USD","ARTY","TSLR","BITQ","GB00BDT5M118.USD","IE0004091025.USD","LU1861558580.USD","LU2931357623.SGD","FANG","WNTR","LU2746668974.SGD","LU1629891620.HKD","IMST","MSOO","LU0476273544.USD","LU1232071149.USD","LU2420271590.USD","LU2097829019.USD","LU2403377893.USD","QQQX","LU1720051017.SGD","MSTX","LU2326559502.SGD","LU1989764664.SGD","WUGI","EGGY","BK4581","LU0205194284.USD","LU2462157665.USD","LU2750360997.AUD","LAZR","LU1066053197.SGD","LU2322448791.USD","LU0949170772.SGD","LU2756315318.SGD","GPIQ","SOXY","IE00B19Z8X17.USD","09766","BK4533","LU1069347547.HKD","BK4020","LU2360107168.USD","LU2023250330.USD","TEXX","CRWL","LU1852331112.SGD","LU0353189763.USD","MST","LU0672654240.SGD","BK4515","BK4598","LU2168564149.EUR","LU1066051225.USD","LU2602419157.SGD","SMI3.UK","MRVX","LU0316494557.USD","MSTY.UK","07568","LU1551013425.SGD","MSST","09834","BK4574","LU1116320901.HKD","BK4023","LU2168564065.EUR","LU0786609619.USD","IE00BJLML261.HKD","HAKY","09366","CRWC","07799","07366","BK4213","LU1235294995.USD","RULE","LU1267930490.SGD","LU0345770308.USD","LU1861215975.USD","LU1066051811.HKD","LU0127658192.USD","LU1119994496.HKD","NJAN","IE00B19Z9505.USD","LU1917777945.USD","LU0738911758.USD","TSLY","LU1989764748.USD","WATS","LU2244417387.USD","LU1992135399.USD","LU1670627923.USD","LU0203345920.USD","TSLI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728971","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728971?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:40","pubTimestamp":1787226007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Glaukos (GKOS) and Ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU0823416689.USD","LU2362541513.USD","BIB","IE00BJJMRZ35.SGD","LU0109394709.USD","LU1674673428.USD","LU0256863811.USD","LU2362541273.HKD","LU2462157665.USD","PBE","LU2362540622.SGD","SG9999001176.USD","BK4585","IE00B19Z3B42.SGD","IBBQ","LU1069344957.HKD","BK4588","GKOS","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU2417539215.USD","SGXZ57979304.SGD","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0002141913.USD","IE00BZ9MQY76.HKD","GNMX","IE0002270589.USD","VRTX","LU0417517546.SGD","LU1093756325.SGD","LU0079474960.USD","LU1430594728.SGD","SG9999001176.SGD","LU0889565916.HKD","LU2237438978.USD","BK4548","LU0289739699.SGD","LU2324357040.USD","LU1093756168.USD","LU0234570918.USD","LU2089984988.USD","IE0009355771.USD","BK4567","LU0058720904.USD","BK4139","LU1674673691.USD","LU2236285917.USD","IE00B19Z3581.USD","BK4532","LU2468319806.SGD","LU1585245621.USD","BBH","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0061475181.USD","IBB","LU1878469433.USD","IDNA","LU0432979614.USD","IE0009354923.USD","SG9999013999.USD","TBXU","LU1778281490.HKD","LU2456880835.USD","LU1035775433.USD","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660567400","title":"Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 11 of 19 Names at New Peaks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660567400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660567400?lang=en_us&edition=fundamental","pubTime":"2026-08-20 17:24","pubTimestamp":1787217854,"startTime":"0","endTime":"0","summary":"Insight Guru says Health Care dominates mid-cap 52-week highs list, with 11 of 19 names at new peaksInsight Guru flagged 19 Russell 3000 mid-cap stocks at 52-week highs, led by Biogen at about USD 32.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL1XGRhX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0742534661.SGD","IE00B19Z9P08.USD","LU0006061336.USD","LU0048573561.USD","BMED","LU0320765992.SGD","LU0889565916.HKD","LU1059921491.USD","BIIB","BK4532","LU0234570918.USD","PBE","BK4585","LU0251131958.USD","BK4533","LU2237438978.USD","IE00B19Z9Z06.USD","BK4139","IE00B894F039.SGD","BK4588","BK4550","BK4196","LH","LU0109394709.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402506","title":"Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402506?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:31","pubTimestamp":1787214660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. surged 13% to 5.39 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25698.49.The stock's rise snapped a two-day losing streak.Sino Biopharmaceutical Ltd. closed 41% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 9.6% and Amgen Inc. remained unchanged.Trading volume totaled 382.5 million shares, compared to the 50-day average of 95.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1571399168.USD","LU0122379950.USD","IE00BZ08YR35.GBP","IE00BJT1NW94.SGD","BK4581","LU2242646821.SGD","AMGN","LU0109394709.USD","IE0009355771.USD","LU2089984988.USD","BK4533","IE00BJJMRZ35.SGD","LU1023059063.AUD","PJP","BK4585","IBB","IE0002141913.USD","BBH","01177","LU0058720904.USD","IBBQ","LU0289739699.SGD","LU1057294990.SGD","LU0889565916.HKD","LU2242652126.USD","BK4139","IE00BFTCPJ56.SGD","LU2112291526.USD","SG9999001440.SGD","LU1983299246.USD","BK4588","BK1589","HK0000165453.HKD","LU0320765992.SGD","TBXU","LU1061106388.HKD","IE00B4R5TH58.HKD","BK4599","LU2468319806.SGD","LU0868494617.USD","BK1191","IE00B2B36J28.USD","IE00BZ08YS42.EUR","BIB","PBE","BK1521","BK4566","BK1515","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479477","title":"Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479477","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:37","pubTimestamp":1787182673,"startTime":"0","endTime":"0","summary":"Vertex Resource Group Ltd. ( ($TSE:VTX) ) has issued an update. Vertex Resource Group Ltd. reported stronger second-quarter 2026 results, highlight...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0566484027.USD","IE0002270589.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","PBE","SGXZ57979304.SGD","GNMX","IE00BJJMRZ35.SGD","VERX","LU2237438978.USD","LU2362541513.USD","BIB","BK4533","TBXU","IE00B4R5TH58.HKD","LU0058720904.USD","LU0289739699.SGD","LU2089984988.USD","BK4532","IE00BFTCPJ56.SGD","LU2456880835.USD","LU1815336091.USD","BK4023","LU0320765992.SGD","IE00BZ9MQY76.HKD","BK4585","LU1778281490.HKD","SG9999001176.SGD","IBB","BBH","IDNA","SG9999013999.USD","LU0256863811.USD","SG9999001176.USD","LU0234570918.USD","LU0889565916.HKD","LU1035775433.USD","LU0061475181.USD","BK4588","VRTX","IE00B19Z3581.USD","LU1093756325.SGD","LU2236285917.USD","IE00B19Z9Z06.USD","IE0002141913.USD","IE00B19Z9P08.USD","LU2462157665.USD","IE0009355771.USD","IBBQ","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479247","title":"Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479247?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:29","pubTimestamp":1787182181,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals released an interim H1 2026 results presentation outlining...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-outlines-h1-2026-progress-in-radiopharmaceutical-and-precision-medicine-units?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-outlines-h1-2026-progress-in-radiopharmaceutical-and-precision-medicine-units?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","FDIF","TMAT","IDNA","JDOC","BK4139","GNMX","SYNB","GNOM","WDNA","BMED","HELX","GDOC","TLX","PBE","XT","IBB","HTEC","MEDX","LFSC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282476","title":"Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282476","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:31","pubTimestamp":1787178660,"startTime":"0","endTime":"0","summary":"Profit margin %                           28 %       24 %      26 %      23 %. Adjusted EBITDA %                         18 %       13 %      15 %      11 %.   See \"Non-IFRS Financial Measures\"HIGHLIGHTS FOR THE THREE MONTHS ENDED JUNE 30, 2026-- Net revenue increased $1.0 million over prior period while G&A expenses. -- Profit margin improved to 28.4% of net revenue, up from 24.3% in 2025.-- Adjusted EBITDA increased by $2.8 million, or 43.8%, compared to 2025,with Adjusted EBITDA growth in both the Environmental Consulting and. -- Returned to profitability with net income of $1.0 million, representing a. -- Free cash flow increased to $4.6 million from $1.3 million in Q2 2025.HIGHLIGHTS FOR THE SIX MONTHS ENDED JUNE 30, 2026-- Environmental Consulting net revenue increased by 7.8% compared to H1. -- G&A expenses were reduced by 6.5% compared to H1 2025.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0889565916.HKD","SPHQ","GNMX","IE0009355771.USD","LU0109394709.USD","BIB","LU2456880835.USD","IBB","BK4139","LU2462157665.USD","SG9999013999.USD","LU1674673691.USD","IE00B4R5TH58.HKD","LU0823416689.USD","LU0417517546.SGD","BK4533","LU1674673428.USD","LU0320765992.SGD","IBBQ","IE00B2B36J28.USD","LU1815336091.USD","SG9999001176.SGD","IE00B19Z3581.USD","BK4588","LU0079474960.USD","LU0757428866.USD","IE00B19Z9Z06.USD","LU2468319806.SGD","IE0002141913.USD","LU0061475181.USD","LU1069344957.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IDNA","PBE","SG9999001176.USD","LU0058720904.USD","BBH","LU0256863811.USD","IE00B19Z9P08.USD","LU0566484027.USD","VRTX","LU0432979614.USD","IE00B894F039.SGD","TBXU","LU1035775433.USD","IE00BJT1NW94.SGD","LU2089984988.USD","VERX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660737004","title":"Crinetics Faces Shareholder Challenges to Vertex Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660737004","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660737004?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171563,"startTime":"0","endTime":"0","summary":"An update from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On July 6, 2026, Crinetics agreed to be acquired by Vertex Pharmaceuticals v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2417539215.USD","LU2456880835.USD","LU1069344957.HKD","VRTX","IBB","LU2089984988.USD","BIB","LU0234570918.USD","LU1815336091.USD","LU2462157665.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","VERX","IE00B19Z3581.USD","IE00B19Z9P08.USD","BK4533","SGXZ57979304.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","BBH","IBBQ","BK4585","SG9999013999.USD","LU1585245621.USD","LU1035775433.USD","IE00B4R5TH58.HKD","LU1778281490.HKD","GNMX","LU0320765992.SGD","SG9999001176.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","SG9999001176.USD","LU1093756168.USD","PBE","IDNA","TBXU","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU1674673691.USD","LU0256863811.USD","BK4567","BK4139","LU2362541513.USD","LU0566484027.USD","LU0432979614.USD","BK4588","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}